Advanced Drug Delivery Systems Market Size and Forecast 2024-2033|Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG

The Advanced Drug Delivery Systems Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Advanced Drug Delivery Systems Market:

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

According to The Business Research Company’s Advanced Drug Delivery Systems Global Market Report 2024, The advanced drug delivery systems market size has grown strongly in recent years. It will grow from $256.43 billion in 2023 to $272.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%.  The  growth in the historic period can be attributed to improved patient compliance, drug patent expirations, personalized medicine, chronic disease prevalence, biologics and large molecule drugs.

The advanced drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $348.27 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.  The growth in the forecast period can be attributed to patient-friendly routes of administration, focus on rare diseases, digital health integration, patient-centric drug development, telehealth influence, gene therapy and rna therapeutics, exosome-based drug delivery, remote monitoring devices. Major trends in the forecast period include nanotechnology advancements, smart drug delivery systems, 3d printing in drug formulations, integration of artificial intelligence, sustainable drug delivery.

The increasing prevalence of chronic conditions is expected to propel the growth of the advanced drug delivery systems market going forward. Chronic conditions are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Various risk behaviors, including tobacco use and exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use, cause chronic diseases. Advanced drug delivery systems allow targeted delivery of therapeutic agents to specific sites in the body affected by chronic conditions. They ensure the drug reaches the intended site of action, increasing its effectiveness and minimizing side effects. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases are responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans each year. Therefore, the increasing prevalence of chronic conditions is driving the growth of the advanced drug delivery systems market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12683&type=smp

The advanced drug delivery systems market covered in this report is segmented –

1) By Type: Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types

2) By Carrier Type: Liposomes, Nanoparticles, Microspheres, Monoclonal Antibodies, Other Carrier Types

3) By Technology: Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies

4) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS (Central Nervous System), Ophthalmology, Inflammatory Diseases, Infections, Other Applications

5) By End User: Hospitals, Specialized clinics, Clinical Research And Development Centers

Advancements in technology are a key trend gaining popularity in the advanced drug delivery systems market. Major companies operating in the advanced drug delivery systems market are adopting new technologies to sustain their position in the market. For instance, in June 2023, Shilpa Medicare Limited, an India-based manufacturer and supplier of API and formulation, launched Molshil, the world’s first oral thin film formulation of a pediatric dose of paracetamol. The new paracetamol formulation will have the benefits of being extremely palatable and easy to administer while also doing away with some of the disadvantages of the pediatric formulations.

The advanced drug delivery systems market report table of contents includes:

1. Executive Summary

2. Advanced Drug Delivery Systems Market Characteristics

3. Advanced Drug Delivery Systems Market Trends And Strategies

4. Advanced Drug Delivery Systems Market – Macro Economic Scenario

5. Global Advanced Drug Delivery Systems Market Size and Growth

.

.

.

26. South America Advanced Drug Delivery Systems Market

27. Brazil Advanced Drug Delivery Systems Market

28. Middle East Advanced Drug Delivery Systems Market

29. Africa Advanced Drug Delivery Systems Market

30. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles

Top Major Players:

• Pfizer Inc
• Johnson and Johnson Services Inc
• Roche Holding AG
• Abbvie Inc
• Bayer AG

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model